Shattuck Labs, Inc. (STTK) Key Metrics

NASDAQ: STTKValuation, returns, debt and efficiency ratios over 8 years.

STTK valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$544.0M
Enterprise value
$433.7M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
544.0
10-yr median 166.4
Price / book
3.0
10-yr median 1.7
EV / EBITDA
—
Dividend yield
—
Beta
1.10

STTK key metrics, 2018–2025

Fiscal year ended December 31, 2025 · U.S. dollars

STTK valuation Price multiples at each fiscal year-end price.

Price / sales+2,265.9%
254.0
2025 · hover or tap a bar for each year
2020: 220.42021: 11.9 (−94.6%)2022: 149.5 (+1,154.5%)2023: 183.3 (+22.6%)2024: 10.7 (−94.1%)2025: 254.0 (+2,265.9%)
20182025
Price / book+299.7%
3.1
2025 · hover or tap a bar for each year
2020: 7.12021: 1.3 (−81.4%)2022: 0.6 (−58.0%)2023: 2.1 (+279.3%)2024: 0.8 (−63.3%)2025: 3.1 (+299.7%)
20182025
Free cash flow yield+82.9 pts
−15.7%
2025 · hover or tap a bar for each year
2020: −1.6%2021: −18.2% (−16.6 pts)2022: −108.9% (−90.7 pts)2023: −26.9% (+82.0 pts)2024: −98.6% (−71.7 pts)2025: −15.7% (+82.9 pts)
20182025

STTK valuation history

Fiscal year-endToday8-year median

STTK returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

STTK debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

STTK cash returned to shareholders

DividendsBuybacksFree cash flow

STTK price vs earnings per share

Share price at year-endEPS (right axis)

STTK key metrics

2018–2025
Shattuck Labs, Inc. key metrics by fiscal year
20252024202320222021202020192018
Valuation
Market capitalization$254.0M$61.4M$303.7M$97.5M$357.7M$2.19B——
Enterprise value$178.3M−$8.2M$177.3M−$58.9M$88.9M$1.86B——
Price / sales254.010.7183.3149.511.9220.4——
Price / book3.10.82.10.61.37.1——
EV / sales178.3-1.4107.0-90.33.0187.3——
Earnings yield−19.2%−122.8%−28.7%−103.2%−12.6%−1.6%——
Free cash flow yield−15.7%−98.6%−26.9%−108.9%−18.2%−1.6%——
Shareholder yield (dividends + buybacks)—0.0%0.0%0.0%0.0%0.0%——
Share price at fiscal year-end$3.65$1.21$7.13$2.30$8.51$52.41——
Per share
Revenue per share$0.01$0.11$0.04$0.02$0.71$0.24$0.24—
Earnings per share−$0.70−$1.49−$2.05−$2.37−$1.07−$0.85−$0.57—
Operating cash flow per share−$0.57−$1.19−$1.91−$2.23−$1.36−$0.81−$0.50—
Free cash flow per share−$0.57−$1.19−$1.92−$2.50−$1.55−$0.82−$0.51—
Cash per share$1.12$1.44$3.07$3.81$6.40$8.03$0.94—
Book value per share$1.18$1.57$3.40$4.16$6.47$7.42−$0.83—
Tangible book value per share$1.18$1.57$3.40$4.16$6.47$7.42−$0.83—
Capex per share$0.00$0.00$0.01$0.27$0.19$0.02$0.01—
Debt per share$0.03$0.07$0.10$0.12—$0.17$0.09—
Shares outstanding69.6M50.8M42.6M42.4M42.0M41.8M41.7M—
Change in shares outstanding+37.1%+19.2%+0.5%+0.8%+0.6%+0.1%——
Returns & profitability
Return on equity (ROE)−60.3%−67.2%−54.4%−44.9%−15.5%−25.7%——
Return on invested capital (ROIC)−484.7%−449.4%−381.7%−717.2%————
Return on assets (ROA)−53.6%−60.2%−47.8%−39.9%−13.9%−18.0%−42.4%−10.8%
Return on tangible assets−53.6%−82.8%−54.7%−49.0%−15.1%−10.2%−53.3%−10.8%
Free cash flow margin————−216.7%−346.1%−216.9%−36.0%
Financial health
Total debt$2.4M$3.4M$4.2M$4.9M—$6.9M$3.6M$1.7M
Cash & short-term investments$78.1M$73.0M$130.6M$161.3M$268.8M$335.4M$39.1M$60.4M
Net debt−$75.6M−$69.6M−$126.4M−$156.4M−$268.8M−$328.5M−$35.5M−$58.6M
Debt / equity0.030.040.030.03—0.02——
Debt / assets0.030.040.030.02—0.020.080.03
Current ratio11.708.8812.517.3911.7220.532.123.15
Quick ratio11.708.8812.517.3911.7220.532.123.15
Interest coverage———-33.6-32.8——-2.3
Working capital$75.4M$70.3M$131.8M$159.6M$263.7M$328.8M$22.5M$44.8M
Invested capital$6.7M$10.0M$18.3M$19.8M$3.0M−$18.7M−$70.0M−$69.7M
Tangible asset value$82.4M$79.6M$144.7M$176.2M$271.8M$309.9M−$34.5M−$11.1M
Net current asset value$73.8M$67.8M$128.4M$155.4M$261.5M$306.5M−$37.1M−$13.6M
Graham net-net per share$1.00$1.21$2.72$3.17$5.76$7.14−$0.97—
Capital allocation
Share buybacks (net)—$17,000$53,000$0$0$0——
Capex / revenue7.1%1.0%24.6%1,781.3%26.4%7.3%4.8%5.2%
Capex / depreciation0.020.020.103.785.741.180.884.62
Stock-based compensation / revenue699.5%166.9%418.8%991.1%18.2%12.7%4.7%1.9%
R&D / revenue3,527.3%1,174.8%4,484.6%12,714.6%188.4%377.3%295.5%110.5%
SG&A / revenue1,723.5%333.5%1,165.0%3,233.4%62.4%94.4%58.0%16.9%
Efficiency
Days sales outstanding———965.718.195.5——
Days payables outstanding279.5149.4395.4929.11,556.023.431.830.1
Cash conversion cycle (days)———36.6-1,537.972.1——
Receivables turnover———0.3820.143.82——
Payables turnover1.312.440.920.390.2315.6011.4612.11
Asset turnover0.010.050.010.000.090.050.170.33
Average receivables———$1.7M$1.5M$2.6M——
Average payables$2.3M$2.0M$4.4M$8.6M$5.9M$2.4M$2.5M$2.0M
Intangibles / total assets0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Computed from STTK's annual financial statements (latest annual report filed March 5, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

STTK valuation and financial ratios

Shattuck Labs earned a return on equity of −60.3% and a return on invested capital of −484.7% in fiscal 2025. It ended the year with $2.4 million of debt and $78.1 million in cash and short-term investments, a net cash position of $75.6 million.

See the STTK income statement, the STTK chart for price history, or the STTK stock overview for the latest quote and news.

STTK key metrics FAQ

What is Shattuck Labs's return on equity?

Shattuck Labs's return on equity (ROE) was −60.3% in fiscal 2025: net income of -$48.8 million on average shareholders' equity of $81.0 million.

What is Shattuck Labs's ROIC?

Shattuck Labs's return on invested capital was −484.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Shattuck Labs have?

Shattuck Labs had total debt of $2.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.03 and more cash than debt.

What is Shattuck Labs's free cash flow yield?

Shattuck Labs generated -$40.0 million of free cash flow in fiscal 2025, a free cash flow yield of −15.7% on its market value at year-end ($254.0 million).

What is Shattuck Labs's current ratio?

Shattuck Labs's current ratio was 11.70 at the end of fiscal 2025: current assets were 11.70 times current liabilities.

Biotechnology key metrics